SMS Lifesciences hikes stake in Mahi Drugs

17 Sep 2018 Evaluate

SMS Lifesciences India has further acquired 10,00,000 equity shares of Rs 10 each (21.21%) in Mahi Drugs on September 17, 2018. With this, the total stake of the company as on date in Mahi Drugs is 100.00% and it has become wholly owned subsidiary of the company. 

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

SMS Lifesciences Share Price

767.40 -5.40 (-0.70%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.